| Blood pressure centiles for Great Britain LV Jackson, NKS Thalange, TJ Cole Archives of Disease in Childhood 92 (4), 298-303, 2007 | 275 | 2007 |
| Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes N Thalange, L Deeb, V Iotova, T Kawamura, G Klingensmith, A Philotheou, ... Pediatric diabetes 16 (3), 164-176, 2015 | 139 | 2015 |
| Post-traumatic stress symptoms in mothers of very low birth weight infants 2–3 years post-partum S Åhlund, P Clarke, J Hill, N KS Thalange Archives of women's mental health 12, 261-264, 2009 | 92 | 2009 |
| Model of normal prepubertal growth. NK Thalange, PJ Foster, MS Gill, DA Price, PE Clayton Archives of disease in childhood 75 (5), 427-431, 1996 | 92 | 1996 |
| The relationship between stature, growth, and short-term changes in height and weight in normal prepubertal children V Tillmann, NKS Thalange, PJ Foster, MS Gill, DA Price, PE Clayton Pediatric research 44 (6), 882-886, 1998 | 65 | 1998 |
| Insulin analogues in children with Type 1 diabetes: a 52‐week randomized clinical trial N Thalange, A Bereket, J Larsen, LC Hiort, V Peterkova Diabetic medicine 30 (2), 216-225, 2013 | 59 | 2013 |
| Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity NKS Thalange, DA Price, MS Gill, AJ Whatmore, GM Addison, PE Clayton Pediatric research 39 (5), 849-855, 1996 | 44 | 1996 |
| Treatment with insulin detemir or NPH insulin in children aged 2–5 yr with type 1 diabetes mellitus N Thalange, A Bereket, J Larsen, LC Hiort, V Peterkova Pediatric diabetes 12 (7), 632-641, 2011 | 42 | 2011 |
| Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations CS Zipitis, N Thalange European journal of pediatrics 166, 585-588, 2007 | 38 | 2007 |
| Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine ratio: the adolescent type 1 diabetes cardio-renal intervention trial (AdDIT) ML Marcovecchio, ST Chiesa, J Armitage, D Daneman, KC Donaghue, ... Diabetes Care 41 (9), 1963-1969, 2018 | 37 | 2018 |
| Weight‐sparing effect of insulin detemir: a consequence of central nervous system‐mediated reduced energy intake? D Russell‐Jones, T Danne, K Hermansen, K Niswender, K Robertson, ... Diabetes, Obesity and Metabolism 17 (10), 919-927, 2015 | 35 | 2015 |
| Infradian rhythms in urinary growth hormone excretion NK Thalange, MS Gill, L Gill, AJ Whatmore, GM Addison, DA Price, ... The Journal of Clinical Endocrinology & Metabolism 81 (1), 100-106, 1996 | 29 | 1996 |
| Regular fluctuations in growth hormone (GH) release determine normal human growth MS Gill, NKS Thalange, PJ Foster, V Tillmann, DA Price, PJ Diggle, ... Growth Hormone & IGF Research 9 (2), 114-122, 1999 | 21 | 1999 |
| The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from … N Thalange, L Deeb, G Klingensmith, DR Franco, L Bardtrum, ... Pediatric Diabetes 20 (3), 314-320, 2019 | 19 | 2019 |
| Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes E Niechciał, CL Acerini, ST Chiesa, T Stevens, RN Dalton, D Daneman, ... Diabetes care 43 (5), 1070-1076, 2020 | 15 | 2020 |
| A longitudinal, observational study examining the relationships of patient satisfaction with services and mental well‐being to their clinical course in young people with Type 1 … S Gray, T Cheetham, H McConachie, KD Mann, JR Parr, MS Pearce, ... Diabetic Medicine 35 (9), 1216-1222, 2018 | 15 | 2018 |
| Long-term efficacy and safety of insulin degludec in combination with bolus insulin aspart in children and adolescents with type 1 diabetes N Thalange, LC Deeb, V Iotova, T Kawamura, GJ Klingensmith, ... Diabetologia 57, S395-S395, 2014 | 15 | 2014 |
| Short-term changes in growth and urinary growth hormone, insulin-like growth factor-I and markers of bone turnover excretion in healthy prepubertal children V Tillmann, MS Gill, NKS Thalange, G Birkinshaw, DA Price, WD Fraser, ... Growth Hormone & IGF Research 10 (1), 28-36, 2000 | 15 | 2000 |
| The genomic landscape of rare disorders in the Middle East M El Naofal, S Ramaswamy, A Alsarhan, A Nugud, F Sarfraz, H Janbaz, ... Genome Medicine 15 (1), 5, 2023 | 14 | 2023 |
| Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 … N Thalange, A Bereket, LB Jensen, LC Hiort, V Peterkova Diabetes Therapy 7, 713-724, 2016 | 12 | 2016 |
